


Biotron Revenue
Biotechnology Research • Sydney, New South Wales, Australia • 1-10 Employees
Biotron revenue & valuation
| Annual revenue | $7,457,627 |
| Revenue per employee | $1,865,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $23,900,000 |
| Total funding | No funding |
Key Contact at Biotron
Michelle Miller
CEO & MD
Company overview
| Headquarters | 56 Delhi Rd, North Ryde, New South Wales 2113, AU |
| Phone number | +6120241128 |
| Website | |
| NAICS | 541714 |
| SIC | 283 |
| Keywords | Pharmaceuticals |
| Employees | 1-10 |
| Socials |
About Biotron
Biotron Limited is engaged in the research, development, and commercialisation of drugs targeting significant viral diseases with unmet medical need. The Company has BIT225 in clinical development for HIV-1, and a promising preclinical program for HBV. In addition, Biotron has several earlier stage programs designing drugs that target a class of virus protein known as viroporins which have a key role in the virus life cycle of a very broad range of viruses, many of which have caused worldwide health issues such as Dengue, Ebola, Middle East Respiratory virus, Influenza and Zika viruses.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Biotron has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Biotron has never raised funding before.
Frequently asked questions
4.8
40,000 users



